Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05612867 · ClinicalTrials.gov registry record
Low Dose Vitamin C in Burns >20% Compared to Previous Studies With High Dose Vitamin C
A clinical trial, sponsored by Arrowhead Regional Medical Center.
- Completed
- Registry status
- 54
- Enrollment target
NCT05612867 is a clinical trial that has completed, run by Arrowhead Regional Medical Center. The registered enrollment target is 54 participants.
The verdict
NCT05612867 has completed, sponsored by Arrowhead Regional Medical Center.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
Burn injury is marked by a large release of inflammatory mediators which disrupt the normal capillary barrier and cause a rapid shift of intravascular fluid into interstitial spaces, ultimately leading to shock and death. As such, adequate fluid management and resuscitation is critical for burn patients to prevent further cellular injury. Technologies and medical options such as cardiac output monitoring along with early tube feeding and vitamin C administration have developed slowly over the years. Effective management of the Systemic Inflammatory Response Syndrome response and metabolic derangement is crucial for the survival of burn patients. In particular, vitamin C administration has shown to significantly decreases early post-burn lipid peroxidation, reduce microvascular leak of fluid by preventing endothelial dysfunction, and decreases edema formation in burned tissue. Vitamin C is a cheap and widely available antioxidant which has been shown to significantly effective in positively impacting clinical outcomes in burn resuscitation. We aim to evaluate the efficacy of vitamin C in burns greater than 20% total body surface area on clinical outcomes such as length of hospital stay, total fluid requirements, and mortality.
Interventions
- DIETARY_SUPPLEMENT Vitamin C
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2020-12-12 |
| Est. Completion | 2021-01-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05612867
The ClinicalTrials.gov registry entry for NCT05612867 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arrowhead Regional Medical Center, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitamin C is the first listed.
NCT05612867 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05612867 about?
NCT05612867 is a clinical study titled "Low Dose Vitamin C in Burns >20% Compared to Previous Studies With High Dose Vitamin C". Burn injury is marked by a large release of inflammatory mediators which disrupt the normal capillary barrier and cause a rapid shift of intravascular fluid into interstitial spaces, ultimately leading to shock and death. As such, adequate fluid management and resuscitation is critical for burn pati...
What is the current status of trial NCT05612867?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2020-12-12. Estimated completion is 2021-01-08.
What interventions are being tested in trial NCT05612867?
The interventions under investigation include: Vitamin C (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05612867?
This trial is sponsored by Arrowhead Regional Medical Center, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.